Bicara Therapeutics Stock Forecast - Accumulation Distribution
| BCAX Stock | 16.77 0.35 2.13% |
Bicara Stock outlook is based on your current time horizon.
At this time, the RSI of Bicara Therapeutics' share price is approaching 49 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Bicara Therapeutics, making its price go up or down. Momentum 49
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.54) | EPS Estimate Current Year (2.48) | EPS Estimate Next Year (2.93) | Wall Street Target Price 30.7778 | EPS Estimate Current Quarter (0.53) |
Using Bicara Therapeutics hype-based prediction, you can estimate the value of Bicara Therapeutics Common from the perspective of Bicara Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Bicara Therapeutics using Bicara Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Bicara using crowd psychology based on the activity and movement of Bicara Therapeutics' stock price.
Bicara Therapeutics Implied Volatility | 1.52 |
Bicara Therapeutics' implied volatility exposes the market's sentiment of Bicara Therapeutics Common stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Bicara Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Bicara Therapeutics stock will not fluctuate a lot when Bicara Therapeutics' options are near their expiration.
Bicara Therapeutics after-hype prediction price | USD 16.77 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Bicara Therapeutics to cross-verify your projections. Prediction based on Rule 16 of the current Bicara contract
Based on the Rule 16, the options market is currently suggesting that Bicara Therapeutics Common will have an average daily up or down price movement of about 0.095% per day over the life of the 2026-04-17 option contract. With Bicara Therapeutics trading at USD 16.77, that is roughly USD 0.0159 . If you think that the market is fully incorporating Bicara Therapeutics' daily price movement you should consider acquiring Bicara Therapeutics Common options at the current volatility level of 1.52%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-04-17 Bicara Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Bicara Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Bicara Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Bicara Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Bicara Therapeutics' open interest, investors have to compare it to Bicara Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Bicara Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Bicara. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Bicara Therapeutics Additional Predictive Modules
Most predictive techniques to examine Bicara price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bicara using various technical indicators. When you analyze Bicara charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 26451.81 | 7110.03 |
| Check Bicara Therapeutics Volatility | Backtest Bicara Therapeutics | Information Ratio |
Bicara Therapeutics Trading Date Momentum
| On January 27 2026 Bicara Therapeutics Common was traded for 16.77 at the closing time. The top price for the day was 16.79 and the lowest listed price was 16.41 . The trading volume for the day was 314.2 K. The trading history from January 27, 2026 did not affect price variability. The overall trading delta against the current closing price is 1.79% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Bicara Therapeutics to competition |
Other Forecasting Options for Bicara Therapeutics
For every potential investor in Bicara, whether a beginner or expert, Bicara Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Bicara Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Bicara. Basic forecasting techniques help filter out the noise by identifying Bicara Therapeutics' price trends.Bicara Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bicara Therapeutics stock to make a market-neutral strategy. Peer analysis of Bicara Therapeutics could also be used in its relative valuation, which is a method of valuing Bicara Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Bicara Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Bicara Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bicara Therapeutics shares will generate the highest return on investment. By undertsting and applying Bicara Therapeutics stock market strength indicators, traders can identify Bicara Therapeutics Common entry and exit signals to maximize returns.
Bicara Therapeutics Risk Indicators
The analysis of Bicara Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Bicara Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting bicara stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.03 | |||
| Semi Deviation | 3.39 | |||
| Standard Deviation | 3.81 | |||
| Variance | 14.52 | |||
| Downside Variance | 11.95 | |||
| Semi Variance | 11.51 | |||
| Expected Short fall | (3.43) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Bicara Therapeutics
The number of cover stories for Bicara Therapeutics depends on current market conditions and Bicara Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bicara Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bicara Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Bicara Therapeutics Short Properties
Bicara Therapeutics' future price predictability will typically decrease when Bicara Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Bicara Therapeutics Common often depends not only on the future outlook of the potential Bicara Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bicara Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 54.4 M | |
| Cash And Short Term Investments | 489.7 M |
Additional Tools for Bicara Stock Analysis
When running Bicara Therapeutics' price analysis, check to measure Bicara Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bicara Therapeutics is operating at the current time. Most of Bicara Therapeutics' value examination focuses on studying past and present price action to predict the probability of Bicara Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bicara Therapeutics' price. Additionally, you may evaluate how the addition of Bicara Therapeutics to your portfolios can decrease your overall portfolio volatility.